Evidence map›Paper›PMID 30509692›Full record

ArticleVaccine2019

Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar.

Malavika Rajeev, Glenn Edosoa, Chantal Hanitriniaina, Soa Fy Andriamandimby, Helene Guis, Ravo Ramiandrasoa, Rila Ratovoson, Laurence Randrianasolo, Mamitiana Andriamananjara, Jean-Michel Heraud and 3 more

Abstract read
In one paragraph

Article in Vaccine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Human rabies: prospects for elimination.CAB reviews : perspectives in agriculture, veterinary science, nutrition and natural resources · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Malavika RajeevDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, United States. Electronic address: mrajeev@princeton.edu.
Glenn EdosoaService de Lutte contre les Maladies Épidémiques et Négligées, Ministère de la Santé Publique, Antananarivo, Madagascar.
Chantal HanitriniainaMention Zoologie et Biodiversité Animale, Faculté des Sciences, Université d'Antananarivo, Antananarivo, Madagascar.
Soa Fy AndriamandimbyVirology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Helene GuisEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar; CIRAD, UMR ASTRE, Antananarivo, Madagascar; ASTRE, Univ Montpellier, CIRAD, INRA, Montpellier, France.
Ravo RamiandrasoaVaccination Center, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Rila RatovosonEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Laurence RandrianasoloEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Mamitiana AndriamananjaraDirection des Services Vétérinaires, Ministère chargé de l'Agriculture et de l'Élevage, Antananarivo, Madagascar.
Jean-Michel HeraudVirology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Laurence BarilEpidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
C Jessica E MetcalfDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, United States.
Katie HampsonBoyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK.

Funding

Wellcome Trust 207569Wellcome Trust 207569/Z/17/Z
6 · The paper itself

Abstract

In Madagascar, dog-mediated rabies has been endemic for over a century, however there is little data on its incidence or impact. We collected data over a 16-month period on provisioning of post-exposure prophylaxis (PEP) at a focal clinic in the Moramanga District and determined the rabies status of biting animals using clinical and laboratory diagnosis. We find that animal rabies cases are widespread, and clinic-based triage and investigation are effective ways to increase detection of rabies exposures and to rule out non-cases. A high proportion of rabies-exposed persons from Moramanga sought (84%) and completed PEP (90% of those that initiated PEP), likely reflecting the access and free provisioning of PEP in the district. Current clinic vial sharing practices demonstrate the potential for intradermal administration of PEP in endemic African settings, reducing vaccine use by 50% in comparison to intramuscular administration. A high proportion of PEP demand was attributed to rabies cases, with approximately 20% of PEP administered to probable rabies exposures and an additional 20% to low-to-no risk contacts with confirmed/probable animal or human cases. Using a simplified decision tree and our data on rabies exposure status and health-seeking behavior, we estimated an annual incidence of 42-110 rabies exposures and 1-3 deaths per 100,000 persons annually. Extrapolating to Madagascar, we estimate an annual burden of 282-745 human rabies deaths with current PEP provisioning averting 1499-3958 deaths each year. Data from other clinics and districts are needed to improve these estimates, particularly given that PEP availability is currently limited to only 31 clinics in the country. A combined strategy of mass dog vaccination, enhanced surveillance, and expanded access to PEP along with more judicious guidelines for administration could effectively reduce and eventually eliminate the burden of rabies in Madagascar.

Indexed as

Cost of IllnessEpidemiological MonitoringFacilities and Services UtilizationHumansIncidenceInjections, IntradermalInjections, IntramuscularMadagascarPost-Exposure ProphylaxisRabiesSurvival AnalysisTreatment OutcomeCanine rabiesContact tracingDisease burdenIntradermalPost-exposure treatmentRabies surveillance

Identifiers

PMID30509692
PMCPMC7612383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.